3,3'-dithiobis(sulfosuccinimidyl propionate) and Autoimmune Disease

3,3'-dithiobis(sulfosuccinimidyl propionate) has been researched along with Autoimmune Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chan, FK; Frederiksen, JK; Johnson, M; Lenardo, MJ; Lynch, D; Siegel, RM; Tsien, RY; Zacharias, DA	1

Other Studies

1 other study(ies) available for 3,3'-dithiobis(sulfosuccinimidyl propionate) and Autoimmune Disease

Article	Year
Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science (New York, N.Y.), 2000, Jun-30, Volume: 288, Issue:5475 Topics: Animals; Apoptosis; Autoimmune Diseases; Cell Line; Cell Membrane; Cross-Linking Reagents; Fas Ligand Protein; fas Receptor; Humans; Ligands; Lymphocytes; Lymphoproliferative Disorders; Macromolecular Substances; Membrane Glycoproteins; Mice; Mutation; Point Mutation; Recombinant Fusion Proteins; Signal Transduction; Succinimides; Tumor Cells, Cultured	2000

Article

Year

Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations.

Science (New York, N.Y.), 2000, Jun-30, Volume: 288, Issue:5475

Topics: Animals; Apoptosis; Autoimmune Diseases; Cell Line; Cell Membrane; Cross-Linking Reagents; Fas Ligand Protein; fas Receptor; Humans; Ligands; Lymphocytes; Lymphoproliferative Disorders; Macromolecular Substances; Membrane Glycoproteins; Mice; Mutation; Point Mutation; Recombinant Fusion Proteins; Signal Transduction; Succinimides; Tumor Cells, Cultured

2000